Monday, May 20, 2024 · SEC filings
What the smart money revealed on May 20
882 insider filings came in. We hid 53 planned (10b5-1) sellers and 617 people whose filings were routine, like grants and tax withholding.
3 insiders at Rekor Systems (REKR) bought $148K of stock
Roles: CEO, Chair, Director. Several insiders buying in the same few days is rare.
3 insiders at Fathom (FTHM) bought $134K of stock
Roles: Director. Several insiders buying in the same few days is rare.
Allogene Therapeutics (ALLO) Director Arie Belldegrun bought $5M
1.72M shares on the open market. Not a grant or an option exercise.
BriaCell Therapeutics (BCTX) Director Marc Lustig bought $2M
902,935 shares on the open market. Not a grant or an option exercise.
Treace Medical Concepts (TMCI) CEO John Treace bought $556K
100,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 3 checked quarters beat the typical stock 6 months later.
Nikola (NKLA) CEO Stephen Girsky bought $540K
1M shares on the open market. Not a grant or an option exercise.
Enliven Therapeutics (ELVN) Director Rishi Gupta sold $22.9M
Not marked as a planned 10b5-1 sale. Sold 12% of the shares they held directly. Still holds 7.92M shares.
Home Depot (HD) EVP Matt Carey sold $19.3M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 33,325 shares directly.
Unisys (UIS) Director Roxanne Taylor sold $401K
Not marked as a planned 10b5-1 sale. Sold 91% of the shares they held directly. Still holds 8,009 shares.
Show 61 more real buys
Show 111 more real sales
13F season
Holdings as of Mar 31, 2024 were due May 15
50 funds have filed. 49 filed for the quarter before.
Biggest real insider buys, May 14–20
Open-market buys by officers and directors, filed in the 7 days up to May 20.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.